Idex ASA (IDEX)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 7.500 |
|---|---|
| 52-week range | 2.601 – 12.800 |
| Return, 1 month / 3 months | +32.0% / −7.4% |
| Return, 1 year / 3 years | +145.9% / −92.1% |
| Trend | Below its 200-day average |
| RSI (14) | 58 |
| Volatility (1 year) | 95.1% |
| Worst drawdown (1 year) | -56.9% |
| Average daily value traded | 1.46M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Idex ASA develops fingerprint authentication technology used to confirm a person's identity. Its sensors and software are built into smartphones, payment cards and access-control devices, letting users unlock or authorise transactions with a touch of a finger. The company works with device makers and card issuers that need secure biometric verification. Idex ASA is based in Norway and its business centres on biometric sensor design and related software for consumer and security applications.
Idex ASA trades under the code IDEX on the Oslo Børs in Norway, with its price quoted in Norwegian kroner (NOK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Idex ASA (IDEX) trades on the Oslo Børs in Norway. It last closed at NOK 7.500 on 27 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 229 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 145.9% and over the last three months it fell 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.1% | ||
| From 52-week high | -39.0% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.4% | ||
| 6-month return | -33.3% | ||
| 12-month return, skipping the last month | 86.3% | ||
| Stability (higher is calmer) | 11 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 95.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -56.9% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 1.46M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | +32.0% |
| 3 months | −7.4% |
| 6 months | −33.3% |
| 1 year | +145.9% |
| 3 years | −92.1% |
| 5 years | −98.8% |
Signals
| 50-day / 200-day average | 6.678 / 7.742 |
|---|---|
| Golden / death cross (60 days) | Death, 26 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.511 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.